SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14801366

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APEIRON BIOLOGICS AG1030 WIEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haslinger, Isabella Vienna, AT 2 5
Lametschwandtner, Gunther Vienna, AT 3 12
Loibner, Hans Vienna, AT 61 199
Schuster, Manfred Schrick, AT 47 939
Seidl, Sandra Vienna, AT 2 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation